Journal of the American Pharmacists Association : JAPhA
-
J Am Pharm Assoc (2003) · Jan 2014
ReviewPharmacists' role in addressing opioid abuse, addiction, and diversion.
OBJECTIVE To review the scope of the problem of opioid misuse; explore pharmacists' roles and responsibilities regarding opioid use; discuss existing laws, guidelines, and regulations governing opioid management; identify potential patient and practice management strategies to address opioid abuse; and disseminate leader insights on these issues. DATA SOURCES Information presented at a conference convened by the American Pharmacists Association (Pharmacists' Role in Addressing Opioid Abuse, Addiction, and Diversion; held November 15, 2012) and discussed in conference workgroups, as well as related information from the literature. SUMMARY Opioid misuse, abuse, and diversion has grown dramatically since the early 1990s and affects public health considerably. ⋯ Strategies are available that pharmacists can use to reduce the likelihood of opioid misuse, abuse, and diversion while minimizing the impact on legitimate pain management efforts. These strategies and tools can be used to support (1) the assessment of prescriptions that are presented for opioid medications, (2) the management of patients receiving opioids, and (3) follow-up options when misuse, abuse, or diversion has been identified. CONCLUSION Implementation of systems and processes that support pharmacist management of opioid-related issues under financially viable business models would create a number of opportunities to improve patient care.
-
J Am Pharm Assoc (2003) · Jan 2014
Review Practice GuidelineReprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk.
-
J Am Pharm Assoc (2003) · Jan 2014
Assessment of pain and impact of care among patients with painful diabetic peripheral neuropathy.
OBJECTIVES To assess the prevalence of painful diabetic peripheral neuropathy (DPN), evaluate the impact of DPN on patients' function and quality of life, and assess patient satisfaction with their current DPN treatment. DESIGN Cross-sectional study. SETTING Patient-centered medical home model at an internal medicine clinic in Chicago, from November 1, 2011, through November 1, 2012. ⋯ More than 50% of patients with these symptoms had experienced them for more than 1 year. Fewer than one in five patients (14% [n = 5]) reporting symptoms indicative of painful DPN were receiving treatment. CONCLUSION DPN may be underdiagnosed and undertreated in this patient population, which represents a potential opportunity for pharmacists to help patients with diabetes meet their quality of care goals.
-
J Am Pharm Assoc (2003) · Jan 2014
Facilitating collaboration between pharmacists and physicians using an iterative interview process.
OBJECTIVE To elicit and describe mutually agreed upon common problems and subsequent solutions resulting from a facilitated face-to-face meeting between pharmacists and physicians. DESIGN Descriptive, exploratory, nonexperimental study. SETTING Wisconsin from October to December 2011. ⋯ CONCLUSION Bringing physicians and pharmacists together for a face-to-face interaction that was informed by information gained in previous individual interviews successfully stimulated conversation on ways in which each profession could help the other provide optimal patient care. This interaction appeared to dispel assumptions and build trust. The results of this project may provide pharmacists with the confidence to reach out to their physician colleagues.